298 related articles for article (PubMed ID: 25921026)
1. Choline metabolism-based molecular diagnosis of cancer: an update.
Glunde K; Penet MF; Jiang L; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2015 Jun; 15(6):735-47. PubMed ID: 25921026
[TBL] [Abstract][Full Text] [Related]
2. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
3. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
4. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
[TBL] [Abstract][Full Text] [Related]
5. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
6. Choline metabolism in cancer: implications for diagnosis and therapy.
Glunde K; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2006 Nov; 6(6):821-9. PubMed ID: 17140369
[TBL] [Abstract][Full Text] [Related]
7. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
Glunde K; Serkova NJ
Pharmacogenomics; 2006 Oct; 7(7):1109-23. PubMed ID: 17054420
[TBL] [Abstract][Full Text] [Related]
9. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.
Sonkar K; Ayyappan V; Tressler CM; Adelaja O; Cai R; Cheng M; Glunde K
NMR Biomed; 2019 Oct; 32(10):e4112. PubMed ID: 31184789
[TBL] [Abstract][Full Text] [Related]
10. Targeting Phospholipid Metabolism in Cancer.
Cheng M; Bhujwalla ZM; Glunde K
Front Oncol; 2016; 6():266. PubMed ID: 28083512
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
12. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.
Morse DL; Carroll D; Day S; Gray H; Sadarangani P; Murthi S; Job C; Baggett B; Raghunand N; Gillies RJ
NMR Biomed; 2009 Jan; 22(1):114-27. PubMed ID: 19016452
[TBL] [Abstract][Full Text] [Related]
13. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
[TBL] [Abstract][Full Text] [Related]
14. Choline metabolism in malignant transformation.
Glunde K; Bhujwalla ZM; Ronen SM
Nat Rev Cancer; 2011 Nov; 11(12):835-48. PubMed ID: 22089420
[TBL] [Abstract][Full Text] [Related]
15. Choline Metabolism Alteration: A Focus on Ovarian Cancer.
Bagnoli M; Granata A; Nicoletti R; Krishnamachary B; Bhujwalla ZM; Canese R; Podo F; Canevari S; Iorio E; Mezzanzanica D
Front Oncol; 2016; 6():153. PubMed ID: 27446799
[TBL] [Abstract][Full Text] [Related]
16. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
Glunde K; Shah T; Winnard PT; Raman V; Takagi T; Vesuna F; Artemov D; Bhujwalla ZM
Cancer Res; 2008 Jan; 68(1):172-80. PubMed ID: 18172309
[TBL] [Abstract][Full Text] [Related]
19. ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.
Gokhale S; Xie P
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34202989
[TBL] [Abstract][Full Text] [Related]
20. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines.
Ratnam S; Kent C
Arch Biochem Biophys; 1995 Nov; 323(2):313-22. PubMed ID: 7487093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]